Patents by Inventor Frederick Ray Kinder, Jr.

Frederick Ray Kinder, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted lactams and their use as anti-cancer agents
    Patent number: 7378410
    Abstract: This invention relates to certain substituted lactam compounds of the formula (I), particularly caprolactam compounds, which are useful for the treatment of cancer
    Type: Grant
    Filed: July 23, 2004
    Date of Patent: May 27, 2008
    Assignee: Novartis AG
    Inventors: Kenneth Walter Bair, Frederick Ray Kinder, Jr., Richard William Versace
  • Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors
    Patent number: 6972292
    Abstract: The present invention relates to certain substituted polyketides of formula I, wherein A, B, C, D, E, F and m are as defined herein, pharmaceutical compositions containing said compounds, and the use of said compounds in treating tumors.
    Type: Grant
    Filed: August 5, 2002
    Date of Patent: December 6, 2005
    Assignee: Novartis AG
    Inventors: Frederick Ray Kinder, Jr., Kenneth W. Bair, Timothy M. Ramsey, Michael L. Sabio
  • Use of certain substituted caprolactam carbonates and ethers in treating tumors
    Patent number: 6599898
    Abstract: The present invention relates to certain substituted caprolactam carbonate and ether compounds, pharmaceutical compositions containing said compounds, the use of said compounds in treating tumors and to a process for making said compounds.
    Type: Grant
    Filed: May 17, 2002
    Date of Patent: July 29, 2003
    Assignee: Novartis AG
    Inventors: Frederick Ray Kinder, Jr., Richard William Versace, Kenneth Walter Bair
  • Use of certain substituted caprolactams in treating tumors
    Patent number: 6555533
    Abstract: The present invention relates to certain substituted caprolactam compounds, pharmaceutical compositions containing said compounds, the use of said compounds in treating tumors and to a process for making said compounds.
    Type: Grant
    Filed: March 12, 2001
    Date of Patent: April 29, 2003
    Assignee: Novartis AG
    Inventors: Frederick Ray Kinder, Jr., Kenneth Walter Bair, Christopher Turchik Jagoe, Richard William Versace, Sompong Wattanasin
  • Process for preparing discodermolide and analogues thereof
    Patent number: 6506910
    Abstract: A more practical synthesis for preparing discodermolide and structurally related analogues, novel compounds useful in the process and novel compounds prepared by the process.
    Type: Grant
    Filed: August 3, 2001
    Date of Patent: January 14, 2003
    Assignee: Novartis AG
    Inventor: Frederick Ray Kinder, Jr.
  • Certain substituted caprolactam carbonates and ethers, pharmaceutical compositions containing them and their use in treating tumors
    Patent number: 6413954
    Abstract: The present invention relates to certain substituted caprolactam carbonate and ether compounds, pharmaceutical compositions containing said compounds, the use of said compounds in treating tumors and to a process for making said compounds.
    Type: Grant
    Filed: May 8, 2001
    Date of Patent: July 2, 2002
    Assignee: Novartis AG
    Inventors: Frederick Ray Kinder, Jr., Richard William Versace, Kenneth Walter Bair
  • Certain substituted caprolactams, pharmaceutical compositions containing them and a process for their preparation
    Patent number: 6239127
    Abstract: The present invention relates to certain substituted caprolactam compounds of formula (I), where R1 is (C1-6)alkyl or (C3-6)cycloalkyl; R2 hydrogen or (C1-6)alkyl; X is (C1-12)alkynylene; (C2-12)alkynylene; m is 0 or 1; and R3 is (C3-8)cycloalkyl; or an aromatic ring system selected from (II, III, IV and V), where R4 is hydrogen, chloro, or methoxy; R5 is hydrogen, chloro, (C1-18)alkyl or (C1-18)alkoxy, and Z is oxygen, sulfur, N—H, or N—CH3; or a pharmaceutically acceptable acid addition salt thereof, where possible, pharmaceutical compositions containing said compounds, the use of said compounds in treating tumors and to a process for making said compounds.
    Type: Grant
    Filed: November 17, 1999
    Date of Patent: May 29, 2001
    Assignee: Novartis AG
    Inventors: Frederick Ray Kinder, Jr., Kenneth Walter Bair, Christopher Turchik Jagoe, Richard William Versace, Sompong Wattanasin